Another advantage of single-use bronchoscopes is their power to reduce hospital readmissions.

Preventing Infection

Study: Single-Use Bronchoscopes Can Cut Hospital Readmission Rates by 53%

β€œThe data analysis demonstrates significant clinical benefits of single-use bronchoscopes in reducing readmission rates and patient risk.” -- Dr. Hudson Garrett

Hospitals that perform bronchoscopies can reduce readmission rates by more than half, and potentially lower costs, by adopting single-use flexible bronchoscopes.

That’s according to a new abstract that was submitted and presented at the recently completed CHEST 2021 annual meeting. The study examined the health outcomes of 14,228 patients who underwent a bronchoscopy procedure and found that sterile, single-use bronchoscopes reduced the readmissions rate from 7.7 percent to 3.6 percent — a 53 percent drop — compared with reusable bronchoscopes.

Reducing preventable hospital readmissions is a national priority for payers, providers, and policymakers seeking to improve healthcare and lower costs. Medical device companies such as Ambu A/S and Boston Scientific Corp.,  meanwhile, are developing a range of endoscopes that can be used once and discarded, or have disposable components, to prevent cross-contamination and boost patient safety.

This abstract publication follows a recent safety communication update from the U.S. Food and Drug Administration on reprocessing flexible bronchoscopes. The agency is recommending that healthcare providers consider using single-use bronchoscopes when there is increased risk of spreading infection and when treating COVID-19 patients.

The study — done by Dr. Hudson Garrett, an infection prevention expert — analyzed patient procedures from both inpatient hospitals and outpatient ambulatory facilities. The patient cohort whose procedure was performed with a reusable flexible bronchoscope was 2.3 times more likely to be readmitted within 30 days than the patient group examined with a sterile, single-use flexible bronchoscope, according to the analysis.

The analysis “demonstrates significant clinical benefits,” Garrett wrote in the abstract. Sterile single-use bronchoscopes “should be considered to eliminate reprocessing failures, improve overall operational efficiency, and reduce potential acquisition of healthcare-associated infections.”

Dr. Garrett is an Ambu consultant and an expert in infection prevention, infectious disease, and medical device safety. He’s an adjunct assistant professor of medicine in the Division of Infectious Diseases at the University of Louisville School of Medicine.

Click here to access the published abstract and learn more about the study.


More Pulmonology Articles
Are You Following The Right Pulmonology Influencers?
Best Practices
For a broader look at social media in the medical world, the Healthcare Hashtag Project describes itself as a platform that connects doctors, caregivers, patient advocates and other providers to relevant conversations and communities.
Healthcare Shortage Means High Caseloads for Physicians
Public Health
A ranking of specialties by caseload answers the question of which physicians are responsible for the highest number of patients. Wonder where your specialty comes in?
More From Single-Use Endoscopy
Healthcare and med-tech companies are striving to be sustainability leaders.

Environmental Impact

Med-tech and healthcare companies are among those on the prestigious list, recognized for modifying products with sustainability in mind.

Staff training makes all the difference when it comes to patient safety.

Patient Safety

It all starts with your staff and the training they receive.

A survey of infection preventionists found that product IFUs are sometimes unclear

Public Health

Patient safety depends on it, infection preventionists say.